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Glutamatergic projections from the parabrachial nucleus to the central amygdala are implicated in
pain transmission. In this issue ofNeuron, Delaney et al. identify a new form of adrenergic modulation
at these synapses, demonstrating that noradrenaline-induced suppression of glutamate release is
mediated by a decrease in the number of sites of synaptic transmission without changes in probabil-
ity of release.The role of the amygdala in mediating
emotional aspects of behavioral re-
sponses and pain processing is well
established (LeDoux, 2000; Neugeba-
uer et al., 2003; Maren and Quirk,
2004). It has been repeatedly demon-
strated that different amygdala-based
behavioral processes are under the
modulatory control of noradrenergic
inputs originating in brain stem areas,
such as the locus coeruleus
(McGaugh, 2000). The noradrenaline
release in the amygdala during stress-
ful or emotionally significant events
appears to be needed for the stabiliza-
tion of emotional memory traces, facil-
itating transition of short-term memory
to the long-term form, a process called
memory consolidation. Recent studies
provide evidence that noradrena-
line can promote synaptic plasticity
needed for fear learning either at the
neuronal network level, by changing
the balance between excitatory and in-
hibitory inputs (Tully et al., 2007), or by
facilitating postsynaptic trafficking of
AMPA glutamate receptors (Hu et al.,
2007).
Nociceptive information can be de-
livered to the amygdala, comprised of
several interconnected nuclei, by way
of projections from the somatosensory
cortex and thalamus, and also through
direct inputs from the parabrachial nu-
cleus of the brainstem. Neurons in the
pontine parabrachial nucleus (PB), re-
sponsive to nociceptive stimulation,
project to the central nucleus of the
amygdala (CeA) (Sarhan et al., 2005),
specifically to its capsular and lateral
divisions (CeACandCeAL, respectively).PB conveys nociceptive information
to the CeA through the spino-parabra-
chioamygdaloid pathway, linking the
spinal cord, PB, and CeA, which is an
output amygdala nucleus. Thus, these
projections are directly implicated in
pain transmission. Both the CeAC and
CeAL receive massive noradrenergic
innervation. There is evidence that
such ascending noradrenergic projec-
tions can decrease pain sensation
under stress (Yoshimura and Furue,
2006), but how noradrenaline may ex-
ert this analgesic action is not well un-
derstood. The impressive new study
by Delaney et al. (2007) in this issue
of Neuron provides important mecha-
nistic clues helping to explain this
phenomenon.
Fibers originating in the parabrachial
nucleus terminate on neurons in the
CeAL where they form large basket-
like perisomatic synapses (Sarhan
et al., 2005). Using a ‘‘minimal stimula-
tion’’ approach, the authors recorded
monosynaptic glutamatergic synaptic
responses in the CeAL evoked by sin-
gle-axon stimulation of fibers originat-
ing in PB in the ventral amygdaloid fi-
ber tract in brain slices. Single-fiber
stimulation in this pathway resulted in
unusually large unitary synaptic re-
sponses consisting of 8–10 quanta of
neurotransmitter. It is not clear, how-
ever, whether multiquantal responses
were due to activation of multiple syn-
aptic contacts formed by the branch-
ing axon only or they were also, at least
in part, due to multiquantal release at
individual sites of synaptic transmis-
sion. Regardless, single-fiber stimula-Neuron 56, Dection has produced large excitatory
postsynaptic currents (EPSCs) that
were rapidly suppressed by exoge-
nously applied noradrenaline. Under
more physiological conditions of cur-
rent-clamp recording, when recorded
neurons are allowed to depolarize, sin-
gle-fiber presynaptic stimuli triggered
spike firing in CeAL neurons that was
also suppressed by noradrenaline.
Noradrenergic inhibition at the PB-
CeAL synapses was mediated by
a2-adrenoreceptors, as it was blocked
and mimicked by the specific antago-
nist and agonist of this receptor sub-
type, respectively. What is the synap-
tic site of such modulatory actions of
noradrenaline? Recording asynchro-
nous single quanta synaptic re-
sponses induced by stimulation of
parabrachial fibers under conditions
when extracellular strontium was
substituted for calcium, the authors
demonstrated that the quantal ampli-
tude was not decreased by noradrena-
line, while the size of multiquantal
evoked responses was diminished,
consistent with the presynaptic
mechanism of noradrenaline-induced
suppression of glutamatergic inputs
to CeAL neurons. Nevertheless, the
paired-pulse ratio, inversely depend-
ing on basal probability of release (Pr),
remained unchanged in the presence
of the neuromodulator. This might indi-
cate that the effect of noradrenaline
on glutamatergic neurotransmission at
the PB-CeAL synapses is associated
with a decrease in the number of
sites of synaptic transmission without
changes in Pr.ember 6, 2007 ª2007 Elsevier Inc. 757
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of anatomical connections between
physiologically identified pre- and
postsynaptic neurons indicate that
a single axon may form multiple syn-
aptic contacts on a target neuron
through axonal branching (e.g., see
Markram et al., 1997). However, with
minimal stimulation techniques and
criteria used in the present work to
identify single-fiber responses, one
could not exclude a possibility that
more than one fiber was stimulated if
different fibers had identical or very
similar excitability. Since noradrena-
line can change membrane excitability
by activating potassium conductance
in nerve terminals, it is feasible that
some of the effect on release could
be mediated by decreases in the
number of fibers activated by electric
stimulation. Additionally, multiquantal
release observed at the PB-CeAL syn-
apses under baseline conditions could
be due to release of multiple vesicles of
glutamate from a single active zone. NA
could then decrease the number of
quanta released by a presynaptic ac-
tion potential at individual sites of syn-
aptic transmission. If basket terminals
form multiple synaptic contacts, with
each contact releasing in most cases
a single quantum of neurotransmitter,758 Neuron 56, December 6, 2007 ª2007then the effect of noradrenaline could
result from inactivation of some of the
axonal branches. If the probability of re-
lease at individual release sites is very
low and multiple sites are activated in
response to presynaptic activity, then
paired-pulse ratio might be unchanged
by the neuromodulator (noradrenaline).
The sensitivity of this measure (paired-
pulse ratio) to changes in Pr might be
insufficient if Pr is low at individual re-
lease sites and/or noradrenaline has
a specific effect on sites with the lower
Pr. Electron-microscopic studies per-
formed in combination with electro-
physiological recordings might be
needed to address these issues di-
rectly.
Similar to many other neurotransmit-
ters in the brain, noradrenaline acti-
vates G protein-coupled receptors
(GPCRs) in nerve terminals. The ability
of presynaptic GPCRs to decrease
neurotransmitter release at central syn-
apses is well documented. Most com-
monly, such effects on neurotransmis-
sion are associated with decreased
probability of release, either due to the
direct effect on the voltage-gated cal-
cium channels or the effect on potas-
sium conductance in the nerve termi-
nal’s membrane, also leading to the
decreased calcium influx. As evokedElsevier Inc.release at central synapses steeply de-
pends on intraterminal calcium con-
centration, any decreases in calcium
influx lead to decreased Pr and dimin-
ished synaptic strength. However, the
PB-CeAL synapses utilize a very differ-
ent mechanism of modulation because
the effects of noradrenaline on neuro-
transmission did not involve decreases
in presynaptic calcium influx. It was di-
rectly demonstrated in the experiments
with a low-affinity calcium indicator,
loaded into the PB terminals. Thus, nor-
adrenaline had no affect on Pr, but
apparently decreased the number of
sites of synaptic transmission. It is well
known thata2 adrenoreceptors, shown
to mediate the effects of noradrenaline
in this study, are coupled to Gi/o type
G proteins. Consistent with this, the
authors found that pretreatment of
slices with pertussis toxin prevented
the inhibitory action of noradrenaline
on release. To explore further how the
effects on release could be mediated,
they loaded presynaptic terminals
with the membrane-permeable Gbg-
binding peptide mSIRK and found
that this treatment blocked presynap-
tic inhibition, while mSIRK did not af-
fect neurotransmission when loaded
into postsynaptic neurons. These ob-
servations indicate that the effects of
G protein in presynaptic terminals
were mediated by Gbg subunits acting
on neurotransmitter release down-
stream of calcium influx. This is similar
to the results of previously published
studies in which Gbg have been shown
to decrease release independently of
calcium influx (Blackmer et al., 2001).
Consistent with earlier findings (Ger-
achshenko et al., 2005), cleaving the
Gbg binding sites on the SNAP-25
with botulinum toxin A diminished the
effects of noradrenaline at the studied
synapses, indicating that the effects
on release were due to direct interac-
tions of Gbgwith the machinery of neu-
rotransmitter release. It remains to be
determined, however, why some of
the sites of synaptic transmission get
inactivated in the presence of nor-
adrenaline while others remain active
(Figure 1).
Delaney et al. (2007) provide con-
vincing evidence that the observa-
tions made with exogenously appliedFigure 1. Potential Mechanisms for Noradrenaline-Induced Suppression of
Neurotransmission at the Glutamatergic PB-CeAL Synapses
Activation of presynaptic a2 receptors by noradrenaline causes inactivation of some of the active
zones at synapses where multiquantal release may occur (left panel). Alternatively, it could also
block release at the fraction of synapses containing single release sites (right panel). Under
both scenarios, the effects on release are mediated by direct interactions of Gbg with the release
machinery independently of presynaptic calcium influx.
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vant. They showed directly that en-
dogenous noradrenaline, released by
short trains of high-frequency stimula-
tion delivered to noradrenergic fibers
in slices, produced suppression of
neurotransmission at the PB-CeAL
synapses mediated by a2-adrenore-
ceptor activation. What is the potential
role of the newly described form of
presynaptic modulation by noradrena-
line? A key feature of many central
synapses is that neurotransmission at
the level of single release sites is
somewhat unreliable (Cowan et al.,
2001), with only a fraction of presynap-
tic action potentials resulting in release
of neurotransmitter quanta. However,
neuronal spiking in the brain often oc-
curs in bursts, suggesting that trains
of action potentials invade nerve termi-
nals. During short trains of presynaptic
impulses, probability of release in-
creases in response to subsequent
pulses due to accumulation of residual
calcium that was not removed from the
terminal after the previous action po-
tential. Thus, during neuromodulator-
evoked suppression of release, an in-
hibitory action might be, at least in
part, relieved in the course of repetitive
presynaptic firing. The newly identified
mechanism of presynaptic modulation
is insensitive to the increased levels
of presynaptic activity, as it does not
depend on presynaptic calcium influx
and does not implicate decreases inprobability of release. Thus, the bio-
logical role of such a mechanism
might be to maintain a necessary level
of analgesia under a stressful situation,
despite high levels of presynaptic
firing.
Synaptic mechanisms and organi-
zation may vary widely between differ-
ent cell types and brain structures.
What’s more, they can change, both
by activity and neuromodulators, in
a brain region- and neuromodulator-
specific fashion. It has been previously
shown that the PB-CeAL synapses
can undergo LTP, which is associated
with increased Pr (Lopez de Armentia
and Sah, 2007). It might be important
to explore whether the noradrenaline-
induced suppression of glutamate re-
lease in these synapses interacts with
LTP mechanisms. It would also be in-
teresting to determine whether the
modulatory mechanism at the PB-
CeAL synapses, identified in the excit-
ing work of Delaney et al. (2007), is
specific to the actions of noradrenaline
or whether similar effects could be ob-
served with other neurotransmitters. If
it is noradrenaline specific, it would be
a very interesting example linking an
identified mechanism of presynaptic
plasticity to biologically meaningful
behavioral responses. Although addi-
tional work is clearly needed, this
study furthers our knowledge of how
neurotransmission at central synapses
can be modulated.Neuron 56, DecREFERENCES
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